Too slow to perfuse
Bradycardia or AV block. Trial atropine, but expect limited durability. Epinephrine often does more work.
A large beta-blocker or calcium-channel blocker ingestion is not an antidote quiz. Find the physiology that is failing. Support it while the drug history catches up.
First question: Is the dominant failure rate, pump, pipes, or all three?
Bradycardia or AV block. Trial atropine, but expect limited durability. Epinephrine often does more work.
Weak LV, narrow pulse pressure, cool skin, rising lactate. Start high-dose insulin early. Add inotropy. Call for VA-ECMO before the spiral.
Warm shock with preserved or hyperdynamic LV. Norepinephrine is the workhorse. Massive amlodipine can do this without early bradycardia.
Serial ECG, glucose, lactate, pH, potassium, magnesium, ionized calcium, renal function, urine output, and repeated POCUS. Trend the physiology. One normal snapshot is not clearance.
| Finding | Pulls you toward | What it changes |
|---|---|---|
| Hyperglycemia | CCB | Supports severe CCB physiology. It is not diagnostic. |
| Hypoglycemia | Beta-blocker | Correct it. Do not delay hemodynamic treatment. |
| Vasoplegia + normal HR | DHP CCB | Think amlodipine. Build the pipes lane. |
| Seizure + wide QRS | Propranolol | Give sodium bicarbonate for membrane stabilization. |
| Long QT / torsades | Sotalol | Magnesium, overdrive strategy, and consider dialysis. |
| Depressed LV | Either | High-dose insulin, inotropy, early mechanical-support call. |
Do not run an antidote parade. Atropine. Wait. Glucagon. Wait. Calcium. Wait. Insulin after collapse. That sequence burns the only resource you cannot replace: time.
It improves inotropy and myocardial carbohydrate use. The effect is not instant. Start vasopressors with it. Anticipate hypoglycemia, hypokalemia, and volume load from dextrose.
Pacing may capture the ECG and still produce weak mechanical output in a poisoned myocardium. Confirm a pulse and stroke volume. Do not let the pacer delay metabolic and circulatory support.
Calcium is reasonable in life-threatening CCB poisoning. Glucagon is reasonable for symptomatic beta-blocker bradycardia or hypotension. Either response may be partial or transient.
Evidence for IV lipid emulsion in beta-blocker and CCB shock remains uncertain. Reports include abrupt arrest after administration. Use only after toxicology discussion in selected peri-arrest cases.
Consider when MAP remains inadequate despite catecholamines, vasopressin, calcium, and high-dose insulin, and POCUS shows preserved or hyperdynamic contractility. The best signal is severe vasodilatory CCB shock, especially amlodipine. Evidence is case-level and responses may be transient.
Methylene blue treats vasoplegia. It does not replace flow. Persistent cardiogenic or mixed shock needs early VA-ECMO mobilization or transfer. Do not wait for refractory acidemia and multiorgan failure to make the call.
When the bottle is unclear, treat rate, pump, and pipes. Use glucose, ECG, POCUS, and response to treatment to refine the diagnosis without pausing the resuscitation.
.CARDIOTOXICINGESTION Large suspected [BETA-BLOCKER / CCB / UNKNOWN] ingestion at [TIME], formulation [IR/ER]. Shock phenotype is predominantly [RATE / PUMP / PIPES / MIXED] based on ECG, examination, and serial POCUS. Current support: [PRESSORS + DOSES]. High-dose insulin: [BOLUS / INFUSION RATE] with protocolized glucose and potassium monitoring. Adjuncts given and response: [CALCIUM / GLUCAGON / BICARBONATE / OTHER]. Poison Center / toxicology contacted at [TIME]. ECMO-capable transfer discussion initiated at [TIME]. Hemodynamics and perfusion remain under continuous reassessment.